Retrovirology

Papers
(The TQCC of Retrovirology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Comparative analysis of human microglial models for studies of HIV replication and pathogenesis38
Rotten to the core: antivirals targeting the HIV-1 capsid core32
Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluat30
HIV-1 capsid exploitation of the host microtubule cytoskeleton during early infection25
A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection25
Dynamic nanopore long-read sequencing analysis of HIV-1 splicing events during the early steps of infection23
The HIV-1 capsid and reverse transcription23
Humanized Mice for Infectious and Neurodegenerative disorders21
Extracellular vesicles from HTLV-1 infected cells modulate target cells and viral spread20
Identification of the distribution of human endogenous retroviruses K (HML-2) by PCR-based target enrichment sequencing20
Human T-cell leukaemia virus type 1 associated pulmonary disease: clinical and pathological features of an under-recognised complication of HTLV-1 infection19
Defective HIV-1 genomes and their potential impact on HIV pathogenesis18
HIV infection of non-classical cells in the brain17
HIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules17
MxB impedes the NUP358-mediated HIV-1 pre-integration complex nuclear import and viral replication cooperatively with CPSF617
M-Sec facilitates intercellular transmission of HIV-1 through multiple mechanisms15
Modulation of BRD4 in HIV epigenetic regulation: implications for finding an HIV cure15
Koala retrovirus diversity, transmissibility, and disease associations14
Non-active site mutants of HIV-1 protease influence resistance and sensitisation towards protease inhibitors12
HIV and the tuberculosis “set point”: how HIV impairs alveolar macrophage responses to tuberculosis and sets the stage for progressive disease12
Impact of HIV-1 CRF55_01B infection on the evolution of CD4 count and plasma HIV RNA load in men who have sex with men prior to antiretroviral therapy12
Co-receptor signaling in the pathogenesis of neuroHIV11
Alpha-enolase in viral target cells suppresses the human immunodeficiency virus type 1 integration10
Trim28 acts as restriction factor of prototype foamy virus replication by modulating H3K9me3 marks and destabilizing the viral transactivator Tas10
Advancing our understanding of HIV co-infections and neurological disease using the humanized mouse10
Anti-inflammatory effects of recreational marijuana in virally suppressed youth with HIV-1 are reversed by use of tobacco products in combination with marijuana10
YTHDC1 regulates distinct post-integration steps of HIV-1 replication and is important for viral infectivity10
Seroprevalence of human T-lymphotropic virus infection among blood donors in China: a first nationwide survey9
Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma8
Generation and validation of a highly sensitive bioluminescent HIV-1 reporter vector that simplifies measurement of virus release8
Influence of the amino-terminal sequence on the structure and function of HIV integrase8
Derivation and characterization of an HIV-1 mutant that rescues IP6 binding deficiency8
Addressing an HIV cure in LMIC8
Vpx enhances innate immune responses independently of SAMHD1 during HIV-1 infection8
Characterisation of a highly potent and near pan-neutralising anti-HIV monoclonal antibody expressed in tobacco plants8
0.055016040802002